![Statistical controversies in clinical research: requiem for the 3 + 3 design for phase I trials - Annals of Oncology Statistical controversies in clinical research: requiem for the 3 + 3 design for phase I trials - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/3ca2ce18-2988-439f-9244-3773736cb7af/gr1_lrg.jpg)
Statistical controversies in clinical research: requiem for the 3 + 3 design for phase I trials - Annals of Oncology
![Sequential or combined designs for Phase I/II clinical trials? A simulation study | Semantic Scholar Sequential or combined designs for Phase I/II clinical trials? A simulation study | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f2f0ceca0bcd7847db0c093a4289e64527a23ebd/2-Figure1-1.png)
Sequential or combined designs for Phase I/II clinical trials? A simulation study | Semantic Scholar
![How to design a dose-finding study using the continual reassessment method | BMC Medical Research Methodology | Full Text How to design a dose-finding study using the continual reassessment method | BMC Medical Research Methodology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12874-018-0638-z/MediaObjects/12874_2018_638_Fig6_HTML.png)
How to design a dose-finding study using the continual reassessment method | BMC Medical Research Methodology | Full Text
![How to design a dose-finding study using the continual reassessment method | BMC Medical Research Methodology | Full Text How to design a dose-finding study using the continual reassessment method | BMC Medical Research Methodology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12874-018-0638-z/MediaObjects/12874_2018_638_Fig7_HTML.png)